What is Veradermics 's total current liabilities?

Veradermics (MANE) reported total current liabilities of $6.72M in Q1 2026.

What does total current liabilities mean?

The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Veradermics MANE Total Current Liabilities

Total Current Liabilities at other companies

BeldenBDC

$613.63M+4.3%

Cabot CorporationCBT

$1.07B+30.6%

UnifirstUNF

$290.41M+4.6%

HES

Hess MidstreamHESM

$181.2M-2.6%

MYR GroupMYRG

$827.68M+12.0%

Kura OncologyKURA

$101.5M+13.1%

Other financials

Income statement

See full

Operating income-$29.9M-131%

Net income-$27.2M-120%

EPS (diluted)-$1.32+93.3%

Balance sheet

See full

Cash & equivalents$168.4M+419%

Total debt$4.0K—

Total equity$390.6M+744%

Total assets$397.4M—

Cash flow

See full

Operating cash flow-$21.2M-59.0%

CapEx--100%

Free cash flow-$21.2M-58.7%

Valuation

See full

Market cap$4.99B+296%

Returns & leverage

See full

Return on equity-28.7%—

Current ratio59.1×—

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veradermics 's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veradermics 's total current liabilities?: Veradermics (MANE) reported total current liabilities of $6.72M in Q1 2026.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.